{"disease":{"id":"metabolism-and-nutrition-disorder","name":"metabolism and nutrition disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03223493","title":"Awareness, Care & Treatment in Obesity Management (ACTION) Study","phase":"","overall_status":"COMPLETED","enrollment_count":3767,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT01272219","title":"Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3731,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT03235102","title":"Awareness, Care and Treatment in Obesity Management","phase":"","overall_status":"COMPLETED","enrollment_count":2545,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03548935","title":"STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1961,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT02453711","title":"Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":957,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT03548987","title":"Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":902,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT01272232","title":"Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":846,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT00422058","title":"The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":564,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT00781937","title":"Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":422,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT02963922","title":"Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":396,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT01557166","title":"Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":359,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT02967757","title":"In-market Utilisation of Liraglutide Used for Weight Management in Europe","phase":"","overall_status":"COMPLETED","enrollment_count":316,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02963935","title":"Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":282,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT02918279","title":"Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":251,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT05024032","title":"A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT03669809","title":"The Biological Rhythm of Human Metabolite","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Shandong Provincial Hospital","has_results":false},{"nct_id":"NCT02870231","title":"Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02235961","title":"Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":163,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06422429","title":"Study on the Regulatory Effects of Personalized Innovative Youtiao Intervention on Nutritional Health","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Yu Zhang","has_results":false},{"nct_id":"NCT05785221","title":"Energy Metabolism Profiles Over Weight-loss and Eating Responses","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":117,"lead_sponsor_name":"Chinese Academy of Sciences","has_results":false},{"nct_id":"NCT01044108","title":"A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":117,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT04156165","title":"The Effect of High vs. Moderate Protein Consumption on Human Health","phase":"NA","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"University of Copenhagen","has_results":false},{"nct_id":"NCT03308721","title":"Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02958085","title":"Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02568306","title":"A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06327854","title":"NUtrition and ORal Health in Orthopaedic Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","has_results":false},{"nct_id":"NCT06686199","title":"Potato Diet Intervention Study in a College Population","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Yu Zhang","has_results":false},{"nct_id":"NCT03058107","title":"Tight Caloric Control in the Cachectic Oncologic Patient (TiCaCONCO or CoCooN)","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Universitair Ziekenhuis Brussel","has_results":false},{"nct_id":"NCT03661879","title":"Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03479892","title":"A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03015207","title":"First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02527200","title":"Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT02300844","title":"Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02717858","title":"A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT05864833","title":"METabolism After Orthopedic Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","has_results":false},{"nct_id":"NCT00978393","title":"A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02941042","title":"A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02835235","title":"A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03574584","title":"A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03095807","title":"Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02079870","title":"Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03121885","title":"Human Metabolic Dynamics at Rest and During Aerobic Exercise Under Normobaric Normoxic and Moderate Hypoxic Conditions","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Benjamin Gollasch","has_results":false},{"nct_id":"NCT02696148","title":"A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT04995211","title":"Validity and Reliability of Commercially Available Metabolic Carts","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Pennington Biomedical Research Center","has_results":false},{"nct_id":"NCT03240757","title":"Metabolic and Functional Impact of Various Breakfast Models","phase":"NA","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Ospedale San Donato","has_results":false},{"nct_id":"NCT03697928","title":"Markers of Carnitine Acetyltransferase (CrAT) Protein Activity and Carnitine Availability","phase":"","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Maastricht University","has_results":false},{"nct_id":"NCT03584399","title":"Prospective Evaluation of the Incidence of PICS","phase":"","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Indiana University","has_results":false}],"total":47},"guidelines":[],"source":"Drug Landscape verified database"}